CIK 0001727196
- Non-accelerated filer
Scholar Rock Holding Corp
Sign in to watch- Ticker
- SRRK
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 823750435
- Phone
- +1 857-259-3860
- Business address
- 301 BINNEY STREET, 3RD FLOOR, CAMBRIDGE, MA, 02142
- Open-market buys, last 90 days
- $11,999,922
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$11,999,922. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 84 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-09-21 | Hallal David Chief Executive Officer | Gift | −36,652 | 1,602,382 | ||
| 2026-04-16 | Hallal David Chief Executive Officer | Sale | −30,615 | $49.57 | $1.5M | 1,639,034 |
| 2026-02-09 | Hallal David Chief Executive Officer | Grant or award | +128,004 | 1,669,649 | ||
| 2026-01-13 | Hallal David Chief Executive Officer | Sale | −57,450 | $42.70 | $2.5M | 1,541,645 |
| 2025-10-08 | Hallal David Chief Executive Officer | Gift | −205,000 | 1,599,095 | ||
| 2025-05-02 | Hallal David Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +275,167 | 275,167 | ||
| 2025-04-27 | Hallal David CEO | Grant or award | +250,000 | 554,095 | ||
| 2025-04-27 | Hallal David CEO | Grant or award | +1,250,000 | 1,804,095 | ||
| 2024-06-27 | Hallal David Director | Grant or award | +13,500 | 304,095 | ||
| 2024-06-27 | Hallal David Director | Grant or award · Stock Option (Right to Buy) | +18,000 | 18,000 | ||
| 2023-06-21 | Hallal David Director | Grant or award · Stock Option (Right to Buy) | +36,000 | 36,000 | ||
| 2022-06-16 | Hallal David Director | Grant or award · Stock Option (Right to Buy) | +14,000 | 14,000 |
Page 1 of 1 · 12 trades